POS-045 Evaluating BCX9930, an Oral Factor D Inhibitor for Treatment of Complement-Mediated Kidney Disease: A Proof-of-Concept Study (RENEW)
Titel:
POS-045 Evaluating BCX9930, an Oral Factor D Inhibitor for Treatment of Complement-Mediated Kidney Disease: A Proof-of-Concept Study (RENEW)
Auteur:
Nester, C. Nast, C. Appel, G. Barratt, J. Fervenza, F. Fremeaux-Bacchi, V. Remuzzi, G. Rovin, B. Wong, E. Bourne, E. Marinucci, L. Grayson, D. Patel, R. Sheridan, W.